Medicamen Biotech

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue32.6422.7533.0933.5335.58
Expenses27.9019.3128.9629.3031.31
EBITDA4.743.444.134.234.27
EBIT3.171.922.602.612.67
Profit Before Tax5.083.224.334.144.22
Net Profit3.782.753.593.603.76
Financial Ratios
Operating Profit Margin14.52%15.16%12.48%12.62%12.03%
Net Profit Margin11.58%12.09%10.85%10.74%10.57%
Earning Per Share (Diluted)3.092.242.942.852.98
Dividends Per ShareNA1.00NANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI